Unilab, the leading pharmaceutical company in the Philippines, is once again in the limelight for making the first medicine in the world to combine carbocisteine with zinc, addressing one's cough while strengthening immunity.
Solmux Advance is a significant addition to Unilab’s impressive portfolio of products, which include trusted brands Enervon, Biogesic, Neozep, and Ceelin.
Solmux Advance is a medicine used for the relief of cough characterized by excessive or sticky sputum or phlegm to help treat respiratory tract disorders such as acute or chronic bronchitis and chronic obstructive pulmonary disease (COPD). They are also used in the treatment of otitis media with effusion and glue ear.
About Unilab:
Unilab is the leading pharmaceutical company in the Philippines, a position it has consistently maintained over six decades. Its portfolio includes some of the biggest prescription and over-the-counter brands in the country.
Established in 1945, Unilab is the realization of the vision of its founders, Jose Y. Campos and Mariano K. Tan. It is a strong industry leader distinguished by its corporate philosophy that places the people at the center of everything—Bayanihan. Work revolves around trust, reciprocity, and the sharing of fruits and burdens.
Unilab’s key management officers are Chairman Jocelyn Campos Hess, President and Chief Executive Officer Clinton Andrew Campos Hess, Vice Chairman Mariano John Tan and Executive Vice President and Chief Operating Officer Benjamin Yap.
No comments:
Post a Comment